BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 6239944)

  • 1. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
    Uchida A; Yanagawa E
    J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A; Micksche M; Hoshino T
    Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
    Uchida A; Klein E
    J Natl Cancer Inst; 1988 Nov; 80(17):1398-403. PubMed ID: 3262773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NK cell cytotoxic factor against fresh human tumors.
    Uchida A; Fukata H
    Nat Immun; 1993; 12(4-5):267-78. PubMed ID: 8257831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.